Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
Total
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019   0 67,105,000      
Beginning balance at Dec. 31, 2019 $ (34,913,110) $ 0 $ 67,105 $ 143,826,315 $ (178,806,530) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     12,911,234      
Stock options and warrants exercised, and vesting of restricted shares 47,158,399   $ 12,911 47,145,488    
Common stock issued for preferred stock dividends (in shares)     617,284      
Common stock issued for preferred stock dividends 1,000,000   $ 618 999,382    
Conversion of convertible notes (in shares)     8,384,270      
Conversion of convertible notes 38,735,019   $ 8,384 38,726,635    
Common stock issued for interest on convertible notes (in shares)     312,335      
Common stock issued for interest on convertible notes 988,897   $ 312 988,585    
Stock-based compensation 2,029,218     2,029,218    
Net loss (126,575,218)       (126,575,218)  
Other comprehensive income 1,100,000         1,100,000
Ending balance (in shares) at Jun. 30, 2020   0 89,330,123      
Ending balance at Jun. 30, 2020 (70,476,795) $ 0 $ 89,330 233,715,623 (305,381,748) 1,100,000
Beginning balance (in shares) at Mar. 31, 2020   0 69,493,836      
Beginning balance at Mar. 31, 2020 (21,996,628) $ 0 $ 69,494 150,883,717 (174,049,839) 1,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     12,479,122      
Stock options and warrants exercised, and vesting of restricted shares 46,915,399   $ 12,479 46,902,920    
Common stock issued for preferred stock dividends (in shares)     308,642      
Common stock issued for preferred stock dividends 500,000   $ 309 499,691    
Conversion of convertible notes (in shares)     6,837,381      
Conversion of convertible notes 33,541,467   $ 6,837 33,534,630    
Common stock issued for interest on convertible notes (in shares)     211,142      
Common stock issued for interest on convertible notes 724,685   $ 211 724,474    
Stock-based compensation 1,170,191     1,170,191    
Net loss (131,331,909)       (131,331,909)  
Other comprehensive income 0          
Ending balance (in shares) at Jun. 30, 2020   0 89,330,123      
Ending balance at Jun. 30, 2020 (70,476,795) $ 0 $ 89,330 233,715,623 (305,381,748) 1,100,000
Beginning balance (in shares) at Dec. 31, 2020   0 121,922,532      
Beginning balance at Dec. 31, 2020 395,204,334 $ 0 $ 121,923 504,112,442 (109,030,031) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     1,491,513      
Stock options and warrants exercised, and vesting of restricted shares (69,416)   $ 1,491 (70,907)    
Stock-based compensation 2,032,341     2,032,341    
Net loss (164,125,858)       (164,125,858)  
Other comprehensive income (10,200,000)         (10,200,000)
Ending balance (in shares) at Jun. 30, 2021   0 123,414,045      
Ending balance at Jun. 30, 2021 222,841,401 $ 0 $ 123,414 506,073,876 (273,155,889) (10,200,000)
Beginning balance (in shares) at Mar. 31, 2021   0 123,254,853      
Beginning balance at Mar. 31, 2021 275,604,211 $ 0 $ 123,255 505,017,758 (229,536,802) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     159,192      
Stock options and warrants exercised, and vesting of restricted shares (83,636)   $ 159 (83,795)    
Stock-based compensation 1,139,913     1,139,913    
Net loss (43,619,087)       (43,619,087)  
Other comprehensive income (10,200,000)         (10,200,000)
Ending balance (in shares) at Jun. 30, 2021   0 123,414,045      
Ending balance at Jun. 30, 2021 $ 222,841,401 $ 0 $ 123,414 $ 506,073,876 $ (273,155,889) $ (10,200,000)